Bank Of America Corp Pardes Biosciences, Inc. Transaction History

Bank Of America Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.4 - $1.95 $62,756 - $87,410	-44,826 Reduced 93.5%	3,118 $5,000
Q1 2023 May 12, 2023	BUY	$1.21 - $2.22 $11,180 - $20,512	9,240 Added 23.87%	47,944 $63,000
Q4 2022 Feb 10, 2023	BUY	$0.85 - $1.69 $30,244 - $60,133	35,582 Added 1139.72%	38,704 $65,000
Q3 2022 Nov 14, 2022	SELL	$2.14 - $3.7 $5,463 - $9,446	-2,553 Reduced 44.99%	3,122 $6,000
Q2 2022 Aug 12, 2022	SELL	$2.84 - $8.57 $33,725 - $101,768	-11,875 Reduced 67.66%	5,675 $17,000
Q1 2022 May 16, 2022	BUY	$5.64 - $15.64 $98,982 - $274,482	17,550 New	17,550 $127,000

5.23M

Ticker PRDS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,320,900
Description
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome ...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.